bioRxiv Science⌕ Search

Biology subjects

Eliassaf, A.

Publications and source records attributed to Eliassaf, A..

2 recordsLinked to original sources

Nucleotide insufficiency induced by p53 deficiency leads to replication stress driving genomic instability

P53 prevents DNA damage by inducing repair processes, cell cycle arrest or apoptosis. P53 loss leads to replication stress and genomic instability, yet the mechanisms underlying these effects and their contribution to catastrophic genomic events such as chromothripsis remain poorly understood. Using patient-derived fibroblasts with germline p53 variants, that spontaneously undergo chromothripsis, and p53-downregulated fibroblasts, we discovered that p53 loss leads to aberrant transcriptional upregulation, increasing nucleotide consumption while simultaneously decreasing nucleotide biosynthesis. This imbalance in production and consumption results in insufficient nucleotide pools, leading to replication stress and genomic instability, which are rescued by nucleoside supplementation or transcription normalization. The replication stress triggers telomere dysfunction, micronuclei formation, and ultimately chromothripsis. Emerging dominant chromothriptic clones exhibit normal DNA replication, telomere stabilization, and ecDNA, highlighting critical features for clonal selection. Hence, p53 coordinates transcription and nucleotide pools, crucial for maintaining genomic stability and preventing early cancer development.

cancer biology↗

α-Synuclein Activates the PI3K/AKT Pathway to Drive Lipid Droplets Accumulation: Implications for Parkinson's Disease

Growing evidence supports a metabolic component in Parkinsons disease (PD). - Synuclein (-Syn), a protein central to the onset and progression of PD, facilitates the accumulation of neuronal lipid droplets, which are implicated in disease pathology. We report that AKT is hyper-phosphorylated in PD brains and show that -Syn enhances p110 activity by facilitating palmitoylated Ras localization to the plasma membrane, driving lipid droplet accumulation through PI3K/AKT/mTOR and PPAR{gamma} activation. Phosphorylation of -Syn at Ser129 correlates positively with the localization of Ras to the membrane fraction and with accumulation of lipid droplets. In-vivo treatment of young, asymptomatic -SynA53T transgenic mice with GDC-0084 (paxalisib), a blood- brain barrier-permeable PI3K inhibitor, restored healthy AKT activity levels, reduced levels of PSer129 and -Syn oligomers, decreased neuronal lipid droplet accumulation, and promoted lysosomal clustering. These findings establish a role for -Syn in p110 activation during early, asymptomatic stages of the disease and highlight the therapeutic potential of PI3K inhibition as a disease-modifying strategy. Highlight-Syn activates PI3K/AKT by promoting the localization of palmitoylated Ras to membranes, linking metabolic dysfunction to PD.

neuroscience↗